SCHEMBL22738656

SCHEMBL22738656

Cc1cc(OC(F)(F)F)ccc1-c1cnnc(CN)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 1/20 0.46
CYP1A2 P05177 3/20 0.42
GPR3 P46089 2/20 0.37
FFAR4 Q5NUL3 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
SCN10A Q9Y5Y9 2/20 0.37
MCHR1 Q99705 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
PRMT6 Q96LA8 1/20 0.35
ABL1 P00519 2/20 0.34
GRM7 Q14831 1/20 0.34
KCNH2 Q12809 1/20 0.34
RXRA P19793 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRM5 P41594 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
CTSA P10619 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL22712324 0.93 FFAR4 (0.42) SCN5ACYP1A2FFAR4MCHR1ABL1
SCHEMBL22738657 0.82 SCN5A (0.42) SCN5ACYP1A2GPR3FFAR4MAOA
SCHEMBL20189150 0.81 SCN5A (0.49) SCN5ACYP1A2GPR3FFAR4MAOA
SCHEMBL22712359 0.79 SCN5A (0.40) SCN5ACYP1A2GPR3FFAR4MAOA
Formic Acid SCHEMBL22712358 0.79 SCN5A (0.40) SCN5ACYP1A2FFAR4MAOAMAOB
SCHEMBL22712320 0.79 SCN5A (0.47) SCN5ACYP1A2GPR3FFAR4MAOA
SCHEMBL20188635 0.76 SCN5A (0.49) SCN5ACYP1A2GPR3FFAR4MAOA
SCHEMBL22712325 0.73 SCN5A (0.41) SCN5ACYP1A2FFAR4MAOAMAOB
SCHEMBL28177887 0.70 SCN5A (0.51) SCN5ACYP1A2GPR3FFAR4
SCHEMBL22712339 0.70 CYP1A2 (0.40) SCN5ACYP1A2GPR3FFAR4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773099-B2 Compounds and their methods of use PRAXIS PRECISION MEDICINES, INC. (US) 2023-10-03 US disclosed
US-11773099-B2 Compounds and their methods of use PRAXIS PRECISION MEDICINES, INC. (US) 2023-10-03 US disclosed
US-20200377506-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377506-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B SCN5A 8/4885CYP1A2 1988/4885GPR3 1830/4885
US-11773099-B2 Compounds and their methods of use SCN1A, SCN1B, SCN3A SCN5A 5/4885CYP1A2 1218/4885GPR3 1341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.